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Abstract
Background: Chronic inflammation is a characteristic feature of diabetic cutaneous wounds. We sought to delineate novel
mechanisms involved in the impairment of resolution of inflammation in diabetic cutaneous wounds. At the wound-site,
efficient dead cell clearance (efferocytosis) is a pre-requisite for the timely resolution of inflammation and successful healing.
Methodology/Principal Findings: Macrophages isolated from wounds of diabetic mice showed significant impairment in
efferocytosis. Impaired efferocytosis was associated with significantly higher burden of apoptotic cells in wound tissue as
well as higher expression of pro-inflammatory and lower expression of anti-inflammatory cytokines. Observations related to
apoptotic cell load at the wound site in mice were validated in the wound tissue of diabetic and non-diabetic patients.
Forced Fas ligand driven elevation of apoptotic cell burden at the wound site augmented pro-inflammatory and attenuated
anti-inflammatory cytokine response. Furthermore, successful efferocytosis switched wound macrophages from pro-
inflammatory to an anti-inflammatory mode.
Conclusions/Significance: Taken together, this study presents first evidence demonstrating that diabetic wounds suffer
from dysfunctional macrophage efferocytosis resulting in increased apoptotic cell burden at the wound site. This burden, in
turn, prolongs the inflammatory phase and complicates wound healing.
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Introduction
The Centers for Disease Controla n dP r e v e n t i o n( C D C )r e p o r t
that diabetes affects nearly 21 million Americans i.e., ,7% of the
U.S. population. Impairment of cutaneous wound healing is a
debilitating complication commonly encountered during diabe-
tes mellitus. Foot ulcers represent the most prevalent diabetic
wounds and frequently lead to limb amputations. The incidence
of diabetic foot lesions has been reported to be similar in type 1 vs
type 2 diabetic patients [1]. In human diabetic ulcers, multiple
deviations from normal healing have been identified (reviewed in
[2]. Diabetic ulcers are characterized by a chronic inflammatory
state primarily manifested by imbalances in pro- and anti-
inflammatory cytokines [3]. Transient self-resolving inflamma-
tion is essential for successful wound healing. Wound inflamma-
tion is driven by a variety of mediators that are tightly controlled
in space and time [4,5]. Wound-site macrophages represent a key
player that drive wound inflammation. Diabetes is known to
compromise macrophage function including phagocytosis activ-
ity [6,7]. Diabetic macrophages produce high levels of pro-
inflammatory cytokines [8,9].The causative factors underlying
the chronic inflammatory state ofd i a b e t i cw o u n d sr e m a i nt ob e
characterized.
During the early inflammatory phase, a large number of
polymorphonuclear neutrophil (PMN nearly 50% of all cells at
the wound site) are recruited to the wound site [10]. Following
completion of their tasks, PMN must be eliminated in order to
initiate the next stage of wound healing. Non-resolving
persistent inflammation may derail the healing cascade
resulting in chronic wounds. In the course of adult cutaneous
wound healing, the granulation tissue decreases in cellularity
and evolve into a scar [11]. Rapid increase in cell infiltration
during tissue reconstruction is balanced by apoptosis. Apoptosis
allows for the elimination of cells that are no longer required at
the injury site or cells that are too damaged to facilitate the
healing process. While mechanisms of apoptosis have been
intensely studied, the specific mechanisms of disposal or
clearance of apoptotic cells from the wound site remain poorly
understood [12].
Phagocytosis of apoptotic cells has distinctive morphologic
features and unique downstream consequences. deCathelineau
and Henson [13] and Gardai et al [14] coined the term
efferocytosis [15]. Efferocytosis refers to phagocytosis of apoptotic
cells, an essential feature of immune responses and critical for the
resolution of inflammation. This final removal step in the cell-
death program plays a critical role in protecting tissues from
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prevent further tissue damage by stimulating production of anti-
inflammatory cytokines and chemokines [16,17]. Inappropriate
clearance of cell corpses may lead to autoimmune diseases and
chronic inflammation [18]. Adequate removal of apoptotic PMNs
by macrophages from the wound site is a pre-requisite for the
restoration of normal tissue function resolving inflammation. In
the clinical treatment of chronic wounds, debridement is
commonly practiced and is aimed at the removal of dead,
damaged, or infected tissue to improve the healing potential of the
remaining healthy tissue. We posit that at the wound-site
successful debridement at the cellular level is a pre-requisite to
the resolution of inflammation and successful healing. The
objective of this study was to test this novel hypothesis and to
delineate mechanisms that are involved in the impairment of
resolution of inflammation in diabetic wounds. This reports
presents first evidence collected from functionally active macro-
phages harvested from diabetic wounds.
Results
Mice homozygous (BKS.Cg-m +/+ Leprdb/J or db/db) for
spontaneous mutation of the leptin receptor (Lepr
db) become
identifiably obese around 3 to 4 weeks of age. Elevation of blood
sugar was evident within 4 to 8 weeks after birth. Excisional
(6 mm) wounds created on the back of these mice showed severe
impairment in closure when compared to their corresponding
control (heterozygous db/+) mice (data not shown). Using
histological approaches, we observed that the wounds of diabetic
mice contained higher number of apoptotic cells compared to the
wound tissue of control db/+ mice (Figs. 1A–B). TUNEL staining
and Western blot using active caspase-3 antibody demonstrated
consistent outcomes (Fig. 1C–E). To test the clinical relevance of
the above-said findings punch biopsies (3 mm) were collected from
matched (patient characteristics, wound location and clinical
condition) wounds of consented diabetic and non-diabetic patients
(Table 1). Scoring of active caspase 3 positive cells demonstrated a
Figure 1. Increased number of apoptotic cells in wounds of diabetic mice and humans. A, Representative mosaic images from day 3
wounds of diabetic (db/db) or non-diabetic (db/+) mice stained with active caspase 3 (brown). Counterstaining was performed using
hematoxylin (blue). The mosaic images of whole wounds were collected under 206 magnification guided by MosaiX software (Zeiss) and a
motorized stage. Each mosaic image was generated by combining 12–14 images. Inset: higher magnification image of the boxed area marked in
the mosaic image. scale bar (inset)= 1 0mm; B–C, quantification of active caspase 3 (B) or TUNEL positive cells (C). Data are shown as mean 6 SD
(n=3); *, p,0.05 versus control non diabetic (db/+)m i c e ;D. A representative Western blot image of active caspase-3 (casp-3) and GAPDH
(housekeeping) in day3 wound tissue extracts of diabetic (db/db) or non-diabetic (db/+)m i c e .E. Densitometry data of blot shown in panel D.
Data shown are mean6 SD (n=3). *, p,0.05 compared to db/+ mice; F–G, wound biopsies were obtained from non-diabetic or diabetic patients
presented at the wound clinic. Specimens (3 mm punch) were obtained from the edge of wounds immunostained using active caspase 3 (brown)
antibody as a marker of apoptotic cells. Counterstaining was performed using hematoxylin (blue); F. microscopic images, arrows indicate
positive cells. Scale bar =50 mm; G, quantification of active caspase 3 positive areas shown in F. Data shown are mean 6 SD (n=3); * p, 0.05
versus non diabetic leg wounds.
doi:10.1371/journal.pone.0009539.g001
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individuals with diabetes (1F–G). In order to identify the types of
cells in the diabetic wounds that were undergoing apoptosis, dual
immunofluorescence studies were performed (Fig. 2). Wound
tissue sections (d3 and d7) from diabetic animals were immuno-
stained with active caspase-3 antibody to visualize apoptotic cells.
The sections were then co-immunostained using either anti-
neutrophil or anti-CD31 (endothelial cell marker) antibody
Fig. 2A&B). The results clearly demonstrate that at day 3 majority
of caspase-3 positive cells were neutrophils. Some endothelial cells
were positive for caspase-3 on day 7 post-wounding. These data
suggest PMNs, and endothelial cells at least in part, represent the
apoptotic cells detected in the wounds.
To test whether increased oxidative stress in diabetic mice
contributes to increased number of apoptotic cells in wounds, the
diabetic mice were supplemented (gavaged) daily with N-acetyl
cysteine (NAC). NAC is a well known antioxidant effective in
decreasing oxidative stress in diabetic mice at the abovementioned
dose [19,20]. After three weeks of supplementation, plasma lipid
peroxidation levels were measured as marker for oxidative stress.
Data presented in Fig. S1A demonstrate that diabetic mice,
compared to the matched non-diabetic mice, show significantly
high levels of lipid peroxidation. NAC supplementation for three
weeks significantly decreased plasma lipid peroxidation (Fig. S1A).
4-Hydroxy-2-nonenal (HNE) is a major product of endogenous
lipid peroxidation, which is found as a footprint in the aftermath of
oxidative stress [21]. Anti-HNE staining demonstrated that similar
to plasma, wound tissue of db/db mice exhibit higher levels of
oxidative stress which is ameliorated following NAC supplemen-
tation (Fig. S1B). Despite attenuated oxidative stress following
NAC supplementation, no change in apoptotic cell count in
wounds was observed in the diabetic mice (Fig. S1C). These
observations argue against the involvement of oxidative stress in
determining the apoptotic cell load in the wound tissue of diabetic
mice.
To evaluate apoptotic cell clearance activity, homogenous
wound macrophage suspensions were derived from diabetic and
non-diabetic (control) mice. Wound macrophages were isolated
employing a polyvinyl alcohol (PVA)-sponge implantation ap-
proach. This isolation procedure resulted in macrophage cultures
with .95% (95.961.7%) homogeneity. Wound-site macrophages
were co-cultured with cell-tracker (red)-tagged cells that were
either apoptotic or viable (Fig. 3). Thymocytes were made
apoptotic by activating them with 5 mM dexamethasone for
12 h. Over 90% cells become phosphatidylserine (PS) positive
(Fig. 3A). The co-culture resulted in clasping (Fig. 3B) and
phagocytosis of the fluorescent-labeled apoptotic cells (Figs. 3C).
Macrophages were phagocytotically-silent when co-cultured with
viable cells (Fig. 3D). The difference in observation between
Figs. 3D&E were objectively tested using scores (Fig. 3H). High
powered DIC or fluorescence images were utilized to discriminate
between adherent and engulfed apoptotic cell (Fig. 3F&G).
Table 1. Demographic characteristic of patients and their
wound size/age.
Control Diabetic
Age 48654 5 611
Gender M,F M,F
Race AA,C AA,C
Wound size (mm
3) 2.55-82.11 1.26-66.0
HbA1c ND 4.7-6.0
Wound age .30 d .30 d
AA, African American; C, Caucacians; M, male; F, female; ND, not determined;
doi:10.1371/journal.pone.0009539.t001
Figure 2. Identification of apoptotic neutrophils and endothelial cells in diabetic wounds. Representative immunostained section of: A,
day 3 wound showing neutrophils (green) and active casp-3 (red) staining; and B, day 7 wound showing endothelial cells (CD31, green) and active
casp-3 (red) staining. Nuclear counterstaining was performed using DAPI (blue). i, Low power (20x) images, Scale bar =50 mm.; ii-iv, high powered
images of the boxed area in i showing active casp-3 (red) and DAPI (blue) (ii) anti-neutrophil or anti-CD31 (green) and DAPI (blue) (iii); and merged
images of anti-neutrophil/anti-CD31 and active casp-3. Casp3 positive neutrophils/endothelial cells are shown with white arrows. Scale bar (Aii-iv and
Bii-iv) =10 mm.
doi:10.1371/journal.pone.0009539.g002
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activity of wound macrophages isolated from diabetic mice was
noted (Fig. 4). We sought to test whether the impairment in
apoptotic cell clearance activity of wound macrophages was
limited to the db/db model or macrophages from other diabetic
mice models show comparable results. To address this issue, we
used other genetic models of type 1 diabetes. The NOD/LtJ mice
are susceptible to spontaneous development of autoimmune (type
1) insulin dependent diabetes mellitus (IDDM) [22]. Similarly, B6-
Ins2Akita model of spontaneous type 1 diabetes is a relatively new
model of non-obese insulin-dependent diabetes [22]. Consistent
with results from the db/db mice, wound macrophages derived
from NOD as well as from Akita mice showed increased number
of apoptotic cells in wound tissue (data not shown) as well as clear
impairments in dead cell clearance activity (Figs. 4C&D). Results
addressing the time-course demonstrate that wound macrophages
harvested form non-diabetic mice during the early inflammatory
phase (day 3 post-wounding) possess the highest apoptotic cell
clearance activity (Fig. 4B). This activity is attenuated during the
intermediary (day 7) or late (day 15) phases of healing (Fig. 4B).
Compared to controls, the phagocytic activity was markedly
impaired in macrophages from diabetic mice at all time points
examined (Fig. 4B).
Transient inflammation is an integral component of the
successful healing process [23]. While inflammation-derived
mechanisms support key healing processes such as debris-removal
and angiogenesis, it is necessary that the inflammation be resolved
in a timely manner to allow the remainder of the healing cascade
to follow [23]. To address mechanisms implicated in the resolution
of wound inflammation, wound tissue was harvested from diabetic
mice and their corresponding controls on days 1, 3, and 7 day
post-wounding. Compared to corresponding control mice, diabetic
mice showed increased levels of the pro-inflammatory cytokines
TNF-a and IL-6. Of related interest, IL-10, an anti-inflammatory
cytokine, was significantly lower in the diabetic wound tissue
(Fig. 5A). This line of evidence demonstrates an imbalance
between pro-inflammatory and anti-inflammatory cytokines in the
diabetic wound antagonizing timely resolution of inflammation.
Macrophages represent a major source of cytokines in the wound.
Thus, cytokine production by wound macrophages isolated from
diabetic and control mice was examined. Wound macrophages
from db/db and db/+ control animals were isolated and cultured
overnight. Next, the pro-inflammatory cytokines TNFa, IL-6 were
assayed from the culture media. Macrophages from diabetic mice
produced higher levels of the pro-inflammatory cytokines TNF-a
& IL-6 and lower anti-inflammatory cytokine IL-10 compared to
non-diabetic controls (Fig. 5B). Taken together, the results from
wound tissue (Fig. 5A) as well as isolated wound-site macrophages
(Fig. 5B) demonstrate that the cytokine expression pattern in the
diabetic wound resist resolution of inflammation leading to a
prolonged inflammatory phase.
In the next phase of the study we sought to address whether
there is a link between the observed higher burden of apoptotic
cells in the diabetic wound and impaired resolution of wound
Figure 3. Dead cell clearance by wound-site macrophages. For dead cell clearance assay, wound macrophages were co-cultured with cell-
tracker labeled (red) thymocytes. A, Thymocyte apopotosis detected using Annexin V (FITC conjugated). Annexin V binds to externalized
phosphatidyl serine (PS), a characteristics of apoptotic cells. Such treatment resulted in over 90% cells becoming phosphatidylserine (PS) positive.
Data are mean 6 SD; p,0.05 (n=4). B, F4/80-FITC (green) and DAPI (blue, nuclear) stained wound macrophage establishing link with an apoptotic
thymocyte (red); C, wound macrophage (F4/80-FITC and DAPI stained) engulfed a number of red apoptotic thymocytes; D, co-cultures of control
(untreated, viable) thymocytes (red) with wound macrophage (DIC image) followed by wash; E, co-cultures of apoptotic thymocytes (red) with wound
macrophages (differential image contrast, DIC image) followed by wash; F–G, Representative high magnification image of a macrophage in DIC (F)o r
stained with F4/80 FITC (green, G) showing engulfed and adhered (white arrows) apoptotic thymocytes (red). H, scoring of thymocytes engulfed by
macrophage. Data are presented as phagocytic index which is defined as total number of apoptotic cells engulfed by macrophages in a field of view
divided by total number of macrophage presented in the view. This approach enables normalization of the data against macrophage number. Data
presented as mean 6 SD (n=3). *, p,0.01 compared to macrophage co-cultured with control thymocytes.
doi:10.1371/journal.pone.0009539.g003
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wound site with minimal perturbation of other aspects of wound
biology, JO2 (anti-CD95) or its isotype control (IgG2) antibody
was applied topically to wounds once per day during the early
inflammatory phase (0–4 d post wounding). This approach led to a
significantly higher load of apoptotic cells at the wound site
(Fig. 6A–D). The Fas antigen is a death-domain containing cell
surface protein that is present in many cell types [24]. Our goal, in
using this approach, was to increase apoptotic cell burden caused
by fas-mediated killing of neutrophils. However, we recognize that
there is a possibility that other major cell types e.g. keratinocytes
and macrophage present at the wound tissue may be killed by JO2.
Thus, we chose to experimentally address this potential compli-
cation. Results showed that growing keratinocyte tip cells were not
affected by anti-CD95 JO2 treatment (Fig. 6E). Wound macro-
phages were also not affected by anti-CD95 JO2 treatment (data
not shown). These findings are consistent with published reports
showing that these two cell types both are resistant to CD95-
mediated apoptosis [25,26]. Of outstanding interest was the
observation that increasing apoptotic-cell count at the wound site
caused significant increase in pro-inflammatory cytokine (TNFa,
IL-1b, and IL-6) expression and decreased anti-inflammatory
cytokine (IL-10 and TGFb1) levels at the wound site on days 1 & 3
post-wounding (Fig. 7). Such an augmented inflammatory
response in JO2 treated wounds was associated with impaired
closure as manifested by expanded wound area (Fig. 6F).
Finally, we tested the hypothesis that successful efferocytosis
‘‘switches’’ the wound macrophages from a pro-inflammatory
mode to an anti-inflammatory mode. Following effecrocytosis
wound macrophages were activated with LPS and IFN-c to induce
expression of TNF-a, as a marker of pro-inflammatory mediator.
A significant suppression of inducible TNFa gene and protein
expression was observed in post-phagocytosis macrophages (co-
cultured with apoptotic cells) compared to macrophages that did
not phagocytose (cultured with viable cells) (Fig. 8). These
observations indicate that successful phagocytosis suppresses pro-
inflammatory gene expression in macrophages leading to the
concept that impaired efferocytosis in the diabetic wound may be
responsible for defective resolution of inflammation.
Discussion
Diabetes is known to be associated with impaired phagocytic
function of macrophages [27,28,29,30,31,32]. Findings of this
study collectively present maiden evidence supporting that
increased count of apoptotic cells in cutaneous wounds of diabetic
mice and humans is associated with compromised dead cell
clearance activity of wound macrophages. The major conclusions
of this study are that: i) diabetic wounds have increased apoptotic
cells load which is in part due to impaired apoptotic clearance
activity of the macrophages at the diabetic wound site. This
conclusion is based on the observations that diabetic wounds in
mouse and human have increased apoptotic cell count primarily
contributed by apoptotic PMNs, and that macrophages isolated
from diabetic wounds are impaired in their activity to phagocytose
apoptotic cells; ii) increase in apoptotic cell burden in diabetic
wounds augments inflammatory response in wounds. This
conclusion is based on the observation that experimental elevation
of apoptotic cell load at the wound site resulted in increased
inflammatory response; and iii) impaired dead cell clearance
activity in diabetic wound macrophages compromises resolution of
inflammation in diabetic wounds. This is supported by the
observation that successful clearance of apoptotic cell by wound
macrophages attenuates the expression of inflammatory cytokines
and that diabetic wound macrophages, impaired in their ability to
phagocytose, produce elevated levels of pro-inflammatory
cytokines.
Elevated apoptotic cell count is a known feature of the diabetic
wound [33]. Factors other than impaired phagocytosis by
macrophages, as proposed in this study, that may contribute to
Figure 4. Dead cell clearance activity is impaired in wound-site
macrophages harvested from diabetic mice. A, representative
images of macrophage (phase contrast) from diabetic (db/db) and their
matched control non diabetic (db/+) co-cultured with apoptotic thymo-
cytes (red); B–D, quantification of dead cell clearance activity of wound
macrophages from three different genetic backgrounds; B,p h a g o c y t i c
index of wound macrophages harvested 3, 7 or 15 day post implantation
from db/+ (non-diabetic control) or db/db (type 2 diabetes); C,p h a g o c y t i c
index of wound macrophages harvested day 5 post implantation from NOR
(control) or NOD (type 1 diabetes); and D, phagocytic index of wound
macrophages harvested day 5 post implantation from Akita (Ins2Akita, type
1 diabetes) & C57Bl6 (non-diabetic controls). Data are mean 6SD (n=3).
*, p,0.05 versus control mice.
doi:10.1371/journal.pone.0009539.g004
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acceleration of apoptosis caused by advanced glycation end
products (AGEs), activation of protein kinase C (PKC) and
increased oxidative stress [34]. In support of glycation being
involved in accelerating apoptosis of neutrophils in the peripheral
blood of patients with T2DM a tight association between the rates
of apoptosis with elevated HbA1c has been reported [35].
Implication of oxidative stress in accelerating apoptosis in diabetics
have been proposed [36] but is not supported by observations of
the current study demonstrating the effectiveness of NAC as an
antioxidant but no effect of such intervention on apoptotic cell
burden at the wound site.
Other than accelerated apoptosis, increased apoptotic cells load
at the wound site may be contributed by inefficient clearance of
apoptotic cells from wounds by macrophages. Peritoneal macro-
phages from non-obese diabetic (NOD) mice are known to engulf
apoptotic cells less efficiently than those from non-diabetic mice
[30,32]. Our observation that wound derived macrophages from
three different genetic models of diabetes suffer from impaired
efferocytosis function is consistent with such reports. From a
metabolic and related mechanistic stand-point, NOD and db/db
diabetic mice have several fundamental differences [22,30,37].
NOD mice develop spontaneous autoimmune destruction of b-
cells at approximately 5 month of age. This model has a number of
similarities with features of human type 1 diabetes [22]. In terms of
early onset and an autosomal dominant mode of inheritance and
primary dysfunction of the b cells, Akita mice resemble the
condition of human maturity-onset diabetes of the young [38].
Db/db mouse is an established model of deficient wound healing
associated with human type 2 diabetes mellitus (T2DM) [39,40].
The genetic basis for this inbred mouse model is a single-gene
autosomal recessive defect in leptin receptor which produces leptin
resistance and results in hyperphagia, obesity and the subsequent
symptoms of insulin resistance, insufficient insulin secretion,
hyperglycemia and elevated HbA1c (9.162.1) levels
[22,41,42,43]. One common feature of three above-described
models is that they all suffer from hyperglycemia. Hyperglycemia
associated advanced glycated end products (AGEs) have been
Figure 5. Increased pro-inflammatory cytokine levels in diabetic wounds and in wound-site macrophages. A, Cytokine levels in
excisional wound tissue collected on days 1, 3 and 7 post-wounding were measured using ELISA. Data are presented as pg cytokine levels per mg of
wet tissue. Mean 6 SD (n=5).*, p,0.05 db/db versus db/+; B, PVA sponges were harvested on days 3, 7 or 15 after implantation and macrophages
were isolated. Macrophages (1610
6) were seeded in 6-well plates. Cytokine levels in culture media was measured 24 h post-seeding using ELISA.
Mean 6 SD (n=4). *, p,0.05 db/db versus db/+.
doi:10.1371/journal.pone.0009539.g005
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[31].
Inflammation is tightly regulated by the following two types of
signals: i) initiate & maintain inflammation; and ii) resolve
inflammation [23]. An imbalance between the two signals, in
favor of the former, results in chronic inflammation and derails the
healing cascade. Pro-inflammatory cytokines IL-1a, IL-1b, IL-6
and TNF-a are prominently up-regulated during the repair
process [44]. IL-10 is recognized as a major suppressor of the
inflammatory response [45]. An important role of this anti-
inflammatory cytokine in attenuating the expression of pro-
inflammatory cytokines in fetal wounds resulting in minimized
matrix deposition and scar-free healing has been demonstrated
[46]. Increased levels of the pro-inflammatory cytokines TNF-a
and IL-6 and a decreased level of IL-10, an anti-inflammatory
cytokine were observed in diabetic wound tissue compared to non-
diabetic healing wound. A modest yet significant decrease in IL-10
levels in db/db mice wound compared to non-diabetic control
suggests that IL-10 alone is not sufficient in suppressing the
augmented inflammatory response in the wounds of these mice.
Interestingly, increased expression of IL-10 is known to be
associated with impaired healing in humans chronic venous
insufficiency ulcers [47] that are known to have persistent
inflammation. The specific significance of IL-10 in regulating
diabetic wound inflammation remains to be characterized.
Persistent (day 13 post wounding) expression of the inflammatory
cytokines IL-1a and TNF-a was observed in an excisional wound
healing model in diabetic (db/db) mice [48]. Lowering of the
functionally available levels of the pro-inflammatory cytokine
TNF-a using anti-TNF-a therapy directed at managing activated
macrophages restore diabetic wound healing in ob/ob mice [9].
These lines of evidence suggest that the perturbation of a delicate
balance between pro-inflammatory and anti-inflammatory cyto-
kines in the diabetic wound predisposes the wound to impaired
resolution of inflammation [3,48]. Macrophages represent a major
source of the cytokines in wounds [44]. The kinetics of cytokine
production by wound macrophages was not concurrent with the
dynamics of tissue wound cytokines. However, the observation
that macrophages derived from diabetic wounds produces
increased levels of pro-inflammatory cytokines compared to the
non-diabetic control macrophages support that the augmented
pro-inflammatory state of diabetic wound tissue is at least in part
Figure 6. Topical application of Fas-activating anti-CD95 JO2 to the wound-site increased apoptotic cell count while not inducing
apoptosis in keratinocytes. A, visualization of TUNEL stained apoptotic cells in day 5 wound tissue treated with anti-murine CD95 (clone:JO2,
2 mg/wound) or vehicle containing isotype control (IgG2). Positive control (wound tissue treated with proteinase K and nuclease) showing TUNEL
positive apoptotic cells with green nuclei stain; B, scoring of apoptotic cells in wound tissue sections stained with TUNEL. *, p,0.05 compared to the
paired vehicle-treated wounds; C, a representative Western blot image of active caspase-3 (casp-3) and GAPDH (housekeeping) in tissue extracts from
IgG2 or JO2 treated d3 wounds; D, densitometric data of blot shown in panel C. Data shown are mean 6 SD (n=3). *, p,0.05 compared to IgG2
treated wounds; E, JO2 treatment did not induce keratinocyte apoptosis. Keratin-14 (green), active caspase-3 (red) and DAPI (blue) stained migrating
epithelial tip in placebo (left) or JO2 treated (right) wounds. Scale bar =20 mm. Active caspase-3 staining was observed in the granulation tissue but
not in the hyper-proliferative epithelium or epithelial tip following JO2 treatment; F, wound area as percentage of initial wound determined on the
day 3 after wounding. Data are shown as mean 6 SD (n=4).*, p,0.05 versus corresponding control IgG2 treated wound.
doi:10.1371/journal.pone.0009539.g006
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wound macrophages. This contention is supported by studies using
macrophage depleted mice where a key role of macrophages in
wound cytokine/growth factor dynamics has been demonstrated
[23,49,50]. TNF-a expressing macrophages in diabetic animals
have been also shown to be are primarily responsible for the
impairment of wound healing in this genetic model [9] The
macrophages isolated from CD18 null mice exhibit impaired
phagocytic clearance of PMNs, impaired wound closure and a
marked reduction of TGF-b1, an anti-inflammatory growth factor
released by macrophages [51]. These two studies further support
the contention that the pro-inflammatory state of wound
macrophage plays a major role in compromising the resolution
of inflammation in diabetic wounds.
The Fas/Fas ligand pathway has been implicated as an
important cellular pathway mediating apoptosis in diverse cell
types [52]. Neutrophils are specifically highly susceptible to rapid
apoptosis in vitro after stimulation with activating anti-Fas IgM
(mAb CH-11) [53]. Topical treatment of anti-CD95 JO2
treatment does not induce apoptosis in proliferating keratinocytes
or macrophages. We utilized this opportunity to set up a Fas-
directed approach to increase the apoptotic cell burden at the
wound site. The approach reported in this study served as an
effective tool to query the significance of apoptotic cell burden on
wound biology. Higher apoptotic cell burden at the wound-site
resulted in larger open wound indicating a slower rate of closure.
Contraction, epithelialization and granulation tissue formation
represent the major processes that contribute to the overall wound
healing/closure of full thickness dermal wounds. No effect on
wound epithelialization yet a slower rate of closure suggests that
contraction and/or granulation tissue formation was likely affected
under these conditions. Increased apoptotic cells in wounds also
resulted in elevated the levels of pro-inflammatory cytokines in
wounds supporting the notion that increased apoptotic cell burden
at the wound-site results in augmented inflammatory response.
This is consistent with previous observation in non-wound studies
demonstrating that inappropriate clearance of apoptotic cell
corpses lead to chronic inflammation [18]. Both apoptosis as well
as the efficient clearance of apoptotic cells are important
determinants of the resolution of inflammation in vivo [54,55,56].
Phagocytic removal of apoptotic cells by macrophages is a pre-
requisite for the restoration of normal tissue function resolving
inflammation [56,57,58,59]. Engulfment of apoptotic cells by
macrophages results in potent anti-inflammatory and immuno-
suppressive effects caused by production of anti-inflammatory
cytokines such as TGF-b1, IL-10 & IL-4 and suppressed release of
pro-inflammatory mediators including TNF-a, IL-6 by activated
macrophages [56,60,61,62].
Macrophages are dynamic and heterogeneous cells. Since the
introduction of the concept of alternative activation of macro-
phages in 1992 [63], these cells have been broadly assigned to two
broad groups: (i) classically activated or type I macrophages (M1)
which are pro-inflammatory effectors, and (ii) alternatively
activated or type II macrophages (M2) that possess anti-
inflammatory properties [64]. In response to cues from the
microenvironment, pro-inflammatory activated M1 macrophages
may switch to M2 [65]. Results of this work support that
efferocytosis may be one of such cues that drives the switching of
macrophages towards an anti-inflammatory state [60].
While efferocytosis orchestrates successful resolution of inflam-
mation, this process is also regulated in an autocrine manner by
anti- as well as pro-inflammatory mediators such as TNFa [66].
Once inflammation is resolved, the phenotype of resolution-phase
macrophages has been shown to be altered primarily via cAMP
dependent mechanisms [67]. For the first time, we present
functional results from viable macrophages isolated from the
wound-site in vivo to directly demonstrate that successful
efferocytosis of apoptotic cells results in suppression of a major
pro-inflammatory mediator i.e, TNFa. Understanding the mech-
anisms of resolution of inflammation by wound macrophages as
well as of the post resolution phenotype of macrophages require
further investigation.
In sum, this study provides first evidence that macrophages from
diabetic wounds suffer from impaired in dead cell clearance
activity as one of the key factors resulting in increased apoptotic
Figure 7. Increasing dead cell burden in wounds resulted in
increased pro-inflammatory cytokine levels. Wound tissue
treated with anti-CD95 JO2 or control IgG2 were harvested on days 0,
1 and 3 post-wounding. Cytokine levels from paired (control and
treated) wound tissue were measured using ELISA on the indicated
days post-wounding. Significant increase in pro-inflammatory cytokines
(TNFa, IL-6, IL1b) and decrease in levels of anti-inflammatory cytokines
IL-10 and TGFb1 was noted in wounds that had increased apoptotic cell
load. Data (mean 6SD, n=5) are presented as pg cytokine per mg
wound tissue. *, p,0.05 compared to IgG treated control side.
doi:10.1371/journal.pone.0009539.g007
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inflammatory phase and complicates the healing process and
compromises resolution of inflammation. Correction of impaired
efferocytosis in diabetic wounds and strategies to intercept the
adverse effects of impaired efferocytosis emerge as novel targets for
the management of chronic inflammation commonly noted in
diabetic wounds.
Materials and Methods
Ethics Statement
Vertebrate animals. All animal studies have been approved
by Ohio State University’s Institutional Animal Care and Use
Committee (IACUC).
Human subjects. All human studies were approved by the
Ohio State University’s Institutional Review Board (IRB).
Secondary-Intention Excisional Cutaneous Wound Model
Male (8–12 week aged) mice were used for this study. For
wounding, mice were anesthetized with isoflurane inhalation. Two
6 mm full-thickness (skin and panniculus carnosus) excisional
wounds were placed on the dorsal skin (shaved and cleaned using
betadine), equidistant from the midline and adjacent to the four
limbs. The wound were left to heal by secondary intention
[68,69,70].
Determination of wound area. Imaging of wounds was
performed using a digital camera (Canon PowerShot G6). The
wound area was determined using WoundMatrix
TM software as
described previously [68,69,70]. All animal studies have been
approved by Ohio State University’s Institutional Animal Care
and Use Committee (IACUC).
Polyvinyl Alcohol (PVA) Sponges Implantation
Circular (8 mm) sterile PVA sponges were implanted subcuta-
neously on the back of the mice, a location matched for the site of
excisional wounds [71]. In brief, following induction of anesthesia
by isofluorane inhalation, dorsal midline was shaved and cleaned
with betadine. Two midline 1 cm incisions were made with a
scalpel. Small subcutaneous pockets were created by blunt
dissection, two pockets per animal. Two PVA sponges were
inserted to each pocket. Incisions were closed with skin staples
(9 mm) or suture (3-0 Surgiline
TM). Animals were then returned to
clean cages for the monitoring of recovery. The animals were
euthanized by CO2 inhalation for final harvest of the PVA
sponges.
Isolation of Wound Macrophages from PVA Sponges
Subcutaneously implanted PVA sponges were harvested on a
designated day and a single wound cell suspension was generated
from sponges by repeated compression. The cell suspension was
filtered through a 70 mm nylon cell strainer (Falcon) to remove all
the sponge debris. For macrophage isolations, magnetic cell
sorting was carried out using mouse anti-CD11b tagged microbe-
ads (Miltenyi Biotec, Auburn, CA). This procedure yields a
purified (.95%) population of wound macrophage as determined
by F4/80 staining. Subcutaneously implanted polyvinyl alcohol
(PVA) sponges are extensively used as model for wound-healing
studies especially those addressing inflammation [71,72]. The
model is best suited for acute studies because on a longer term,
after about 4 weeks of implantation, it is known to elicit foreign
body response resulting in giant cell accumulation and fibrosis. In
shorter term studies, the approach represents a reproducible and
biologically valid model for the study of acute healing responses
[72]. No major differences were noted in the cell characteristics
and activity of PVA sponge derived cells and closed incisional
wound derived cells [72]. When compared to excisional wounds,
some differences that are primarily attributed to low-grade
bacterial contamination of open wounds have been reported
[73]. In our excisional wound studies, we routinely check wounds
for bacterial contaminations using procedures described previously
Figure 8. Efferocytosis of apoptotic cells by wound macrophages resulted in suppression of pro-inflammatory TNFa gene and
protein expression. Following apoptotic cell clearance assay the non-phagocytosed thymocytes were removed by washing and cells were
challenged with LPS (1 mg/ml) and IFNc (10 ng/ml) for 4 h (gene expression) or 16 h (protein expression). TNFa gene (A) and protein (B) expression
were measured using real-time PCR and ELISA, respectively. mRNA expression data are presented as % change compared to LPS+IFNc non-activated
control samples. Protein data is expressed as concentration of TNF-a secreted in culture media. Data are mean 6SD (n=4); **, p,0.01 compared to
macrophage cultured with viable cells.
doi:10.1371/journal.pone.0009539.g008
Macrophage Dysfunction
PLoS ONE | www.plosone.org 9 March 2010 | Volume 5 | Issue 3 | e9539[69]. As reported earlier although low grade contamination is
indeed observed in superficial tissues, deep tissue biopsies have not
shown any bacterial contamination [69] suggesting that excisional
wound deep-tissue macrophages are similar to macrophages
derived from the described PVA sponge model.
Apoptotic Cell Clearance Assay
For the assay, wound macrophages were seeded in 8-well
chambered slides. Apoptotic (5 mM dexamethasone treated for
12 h; yield .90% PS positive thymocytes, Fig. 3A) thymocytes
were added to each chamber in a (1:10) macrophage:thymocyte
ratio. Prior to co-culture with macrophages, thymocytes were
labeled with a fluorescence cell-tracker reagent (CellTracker
TM
Orange CMTMR, Molecular Probes). Thymocytes have been
largely used and are well accepted for efferocytosis studies
performed using cultured macrophage ex vivo. Moreover, upon
induction of apoptosis, both PMN and thymocytes are known to
externalize phosphatidyl serine (PS), one of the key mechanisms of
apoptotic cell recognition by macrophages [74,75]. Phagocytosis
assay was performed for 1 h at 37uC. In co-culture studies, shorter
incubation times (10–15 min) were used for adherence assay while
longer (45–60 min) co-culture period were utilized for the
phagocytosis assays [51]. Macrophages were then extensively
washed to remove non-phagocytosed cells. Cells were fixed with
4% paraformaldehyde and stained using F4/80-FITC. Imaging
was performed using a fluorescence microscope (thymocytes, red;
macrophage green or phase contrast). Quantitation of phagocy-
tosed thymocytes by each macrophage was performed using
Axiovision software (Zeiss) by counting 50–100 macrophages from
each well. Data are expressed as ‘‘phagocytic index’’. This index is
defined as the total number of apoptotic cells engulfed per
macrophage present in the field of view [62]. This approach
enables normalization of the data against macrophage number.
Human Subjects and Sample Collection
Subjects participating in the study were chronic wound patients
seen at our Comprehensive Wound Center outpatient clinics that
have been either clinically diagnosed type 2 diabetes (n=3) or no
diagnosis of diabetes (non-diabetic, control; n=3). The demo-
graphic characteristics of patients and wound related information
are listed in Table 1. Protocols were approved by the Ohio State
University’s Institutional Review Board. Declaration of Helsinki
protocols were followed and patients gave their written, informed
consent. Wound (at the wound perimeter) biopsies (3 mm) were
obtained from individual subjects, immediately embedded in
O.C.T compound (Tissue-TekH) and stored frozen in liquid N2 for
histological analysis.
Histology
Formalin-fixed paraffin-embedded or frozen wound specimens
were sectioned. Frozen section (10 mm) or deparaffinized paraffin
sections (4 mm) were immunostained as described earlier [69]
using the anti-active caspase 3 (anti-active caspase 3, Abcam, Inc,
Cambridge, MA) and rabbit anti-HNE (Alexis, AXXORA, LLC,
san Diego, CA) antibody. The sections were subsequently stained
using appropriate HRP or fluorochrome tagged secondary
antibody and counterstaining were performed as described
previously [69]. For the visualization of wound epithelialization,
anti-keratin-14 (1:500; Covance, Berkeley, CA) with appropriate
fluorescence tagged secondary antibody was used. Counterstaining
was performed with DAPI to visualize nuclei (Molecular probe,
OR). Neutrophils and endothelial cells were visualized using anti-
neutrophil (1:100, Serotec, Raleigh, NC) and CD31 (1:200, BD
Pharmingen, San Diego, CA).
TUNEL staining. This assay enables the monitoring of
apoptotic cells in tissue sections and was performed using a
commercially available kit (DermaTACS, Trevigen Inc).
Image quantification. Between 3–5 high powered images
were quantified for each data point from each animal.
Quantification was performed employing a Image processing
tool kit (Adobe Photoshop) software that utilizes a color subtractive
process [76].
Antioxidant Supplementation
Diabetic (db/db) mice were divided in two equal subgroups.
The first group was supplemented (intragastric, daily once) with N-
acetylcysteine (NAC) at a dose of 1 mg/g body weight [19,20].
The control group of mice was supplemented with matched
volume of the vehicle (saline).
Plasma Lipid Peroxidation
As a marker of lipid peroxidation, plasma malondialdehyde
(MDA) levels were detected by the thiobarbituric acid reactive
substances (TBARS) method. The assay was performed using
OXItek TBARS assay kit (ZeptoMetrix Corporation, Buffalo NY).
Wound Tissue Cytokine Analysis
Wound edge tissue [70] was pulverized under liquid nitrogen
followed by extraction of protein in a buffer compatible with
ELISA as described [77]. The cytokine levels in tissue extracts
were measured using commercially available ELISA kits (R & D
Systems).
Wound Macrophage Cytokine Analysis
Macrophages were seeded in 6-well plates and cultured in
RPMI 1640 medium containing 10% heat inactive bovine serum
for 24 h under standard culture conditions. After 24 h, the media
was collected and the cytokine levels in culture media were
measured using commercially available ELISA kits (R & D
Systems).
Western Blot
Western blot was performed as described previously [78,79,80].
Primary antibody against active caspase-3 was obtained from
Abcam.
Statistics
In vitro data are reported as mean 6 SD of at least three
experiments. Comparisons among multiple groups were made by
analysis of variance ANOVA. p,0.05 was considered statistically
significant. For in vivo studies, data are reported as mean 6 SD of
at least 4–6 animals and 3 humans per group.
Supporting Information
Figure S1 Antioxidant supplementation to diabetic mice
attenuates oxidative stress but does not influence apoptotic cell
count in wound tissue. Diabetic db/db mice were supplemented
with N-acetyl-cysteine (NAC, 1 mg/g body weight, daily once) for
three weeks. The control db/db group was supplemented with
matched volume of saline. At the end of three weeks blood glucose,
body weight and plasma MDA levels were measured. Two
excisional (8 mm punch) wounds were placed on the back of mice.
NAC supplementation continued throughout the healing period.
A, Plasma lipid peroxidation (MDA levels) as a marker of oxidative
stress was measured. Data are mean 6 SD; n=6. **, p,0.001
compared to non-diabetic (db/+) group. ##,p ,0.005 compared
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PLoS ONE | www.plosone.org 10 March 2010 | Volume 5 | Issue 3 | e9539to diabetic group supplemented with saline. B, Wound lipid
peroxidation was measured using anti-hydroxynonenal (HNE)
antibody and immunostaining. Data are mean 6SD (n=4), **,
p,0.01 compared to diabetic group supplemented with saline. C,
Apoptotic cell count in wound tissue sections was measured using
active caspase 3 immunohistochemical approach. Quantification
(bar graphs) of caspase 3 positive area was performed using Image
processing Tool kit. Data are shown as mean 6 SD (n=4).
Found at: doi:10.1371/journal.pone.0009539.s001 (0.06 MB
PDF)
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